Trevi Therapeutics
TRVI
#5031
Rank
$1.87 B
Marketcap
$13.19
Share price
2.85%
Change (1 day)
34.32%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2026 (TTM): -$55.57 Million USD

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -$45.35 Million USD, an increase over its 2024 earnings that were of -$47.94 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$55.57 Million22.56%
2025 -$45.35 Million-5.42%
2024 -$47.94 Million67%
2023 -$28.71 Million2.43%
2022 -$28.03 Million-14.45%
2021 -$32.76 Million1.36%
2020 -$32.32 Million23.64%
2019 -$26.14 Million27.54%
2018 -$20.5 Million